- Home
- Publications
- Publication Search
- Publication Details
Title
Innate immune mediators in cancer: between defense and resistance
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 274, Issue 1, Pages 290-306
Publisher
Wiley
Online
2016-10-26
DOI
10.1111/imr.12464
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
- (2016) Henrique Lemos et al. CANCER RESEARCH
- New perspectives on complement mediated immunotherapy
- (2016) Grzegorz Stasiłojć et al. CANCER TREATMENT REVIEWS
- Microbiome and Anticancer Immunosurveillance
- (2016) Laurence Zitvogel et al. CELL
- Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
- (2016) C. Alfaro et al. CLINICAL CANCER RESEARCH
- Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells
- (2016) Nicholas D Huntington et al. CURRENT OPINION IN IMMUNOLOGY
- C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial–mesenchymal transition
- (2016) Wen-Hao Hu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer
- (2016) Chunyan Zhang et al. IMMUNITY
- Recognition of Endogenous Nucleic Acids by the Innate Immune System
- (2016) Axel Roers et al. IMMUNITY
- In situvaccination for the treatment of cancer
- (2016) Linda Hammerich et al. Immunotherapy
- Growing tumors induce a local STING dependent Type I IFN response in dendritic cells
- (2016) Lisa Andzinski et al. INTERNATIONAL JOURNAL OF CANCER
- Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
- (2016) Qing Chen et al. NATURE
- C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
- (2016) Roberta Bulla et al. Nature Communications
- PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
- (2016) X. Xiao et al. Cancer Discovery
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
- (2015) M. Rosario et al. CLINICAL CANCER RESEARCH
- CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
- (2015) Carola H Ries et al. CURRENT OPINION IN PHARMACOLOGY
- Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response
- (2015) Laura Surace et al. IMMUNITY
- Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration
- (2015) Chunmei Piao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs
- (2015) Sharad K. Sharma et al. JOURNAL OF IMMUNOLOGY
- Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis
- (2015) C Ning et al. Mucosal Immunology
- Complement, a target for therapy in inflammatory and degenerative diseases
- (2015) B. Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
- (2015) Alfred L. Garfall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diverse roles of STING-dependent signaling on the development of cancer
- (2015) J Ahn et al. ONCOGENE
- Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma
- (2015) D Ajona et al. ORAL DISEASES
- STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
- (2015) Olivier Demaria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
- (2015) S. Liu et al. SCIENCE
- Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis
- (2015) Takahisa Imamura et al. Breast Cancer
- IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
- (2015) Y. Pylayeva-Gupta et al. Cancer Discovery
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
- (2015) José I. Quetglas et al. Cancer Immunology Research
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- Complement System Part II: Role in Immunity
- (2015) Nicolas S. Merle et al. Frontiers in Immunology
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Complement System Part I – Molecular Mechanisms of Activation and Regulation
- (2015) Nicolas S. Merle et al. Frontiers in Immunology
- Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer
- (2015) Daniel Ajona et al. PLoS One
- Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
- (2015) Selene Nunez-Cruz et al. NEOPLASIA
- B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
- (2014) Nesrine I. Affara et al. CANCER CELL
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
- (2014) S. Suryawanshi et al. CLINICAL CANCER RESEARCH
- Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
- (2014) M. F. Sanmamed et al. CLINICAL CANCER RESEARCH
- Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies
- (2014) M. Dai et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Targeting CD137 enhances the efficacy of cetuximab
- (2014) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
- (2014) O. M. Grauer et al. JOURNAL OF IMMUNOLOGY
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
- (2014) Jared Klarquist et al. JOURNAL OF IMMUNOLOGY
- Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
- (2014) Saskia Meyer et al. mAbs
- cC1qR/CR and gC1qR/p33: Observations in cancer
- (2014) Ellinor I.B. Peerschke et al. MOLECULAR IMMUNOLOGY
- Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
- (2014) Sawa Ito et al. MOLECULAR THERAPY
- C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens
- (2014) L. Baudino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C1q as a unique player in angiogenesis with therapeutic implication in wound healing
- (2014) F. Bossi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation-driven carcinogenesis is mediated through STING
- (2014) Jeonghyun Ahn et al. Nature Communications
- Autocrine Effects of Tumor-Derived Complement
- (2014) Min Soon Cho et al. Cell Reports
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
- (2014) D. Chandra et al. Cancer Immunology Research
- Role of the complement system in NK cell-mediated antitumor T-cell responses
- (2014) Valérie Janelle et al. OncoImmunology
- Anticancer Flavonoids Are Mouse-Selective STING Agonists
- (2013) Sujeong Kim et al. ACS Chemical Biology
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA
- (2013) Pu Gao et al. CELL
- Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
- (2013) H. Nitta et al. CLINICAL CANCER RESEARCH
- Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner
- (2013) Priyadarshini Chatterjee et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
- (2013) Daniel Ajona et al. JNCI-Journal of the National Cancer Institute
- Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
- (2013) Jie Gu et al. LUNG CANCER
- Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation
- (2013) Arije Ghannam et al. MOLECULAR IMMUNOLOGY
- The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes
- (2013) David J. Dowling et al. PLoS One
- The role of complement in CD4+ T cell homeostasis and effector functions
- (2013) Martin Kolev et al. SEMINARS IN IMMUNOLOGY
- Complement inhibition in cancer therapy
- (2013) Ruben Pio et al. SEMINARS IN IMMUNOLOGY
- STING-dependent cytosolic DNA sensing pathways
- (2013) Glen N. Barber TRENDS IN IMMUNOLOGY
- Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells
- (2013) V. Janelle et al. Cancer Immunology Research
- Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer
- (2013) Amelia J. Tesone et al. Frontiers in Immunology
- Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
- (2013) Silvio Bandini et al. OncoImmunology
- Complement activation in astrocytomas: deposition of C4d and patient outcome
- (2012) Katri Mäkelä et al. BMC CANCER
- Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
- (2012) M. C. Ochoa et al. CANCER RESEARCH
- LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response
- (2012) W. Zou et al. CANCER RESEARCH
- Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
- (2012) S. Miyamoto et al. CANCER RESEARCH
- Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
- (2012) Javier Rodríguez et al. EUROPEAN JOURNAL OF CANCER
- 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
- (2012) Daniel Prantner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Opposing Roles for Complement Component C5a in Tumor Progression and the Tumor Microenvironment
- (2012) L. Gunn et al. JOURNAL OF IMMUNOLOGY
- The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics
- (2012) Johana A. Luna Coronell et al. Journal of Proteomics
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
- (2012) Michael G Strainic et al. NATURE IMMUNOLOGY
- STING and the innate immune response to nucleic acids in the cytosol
- (2012) Dara L Burdette et al. NATURE IMMUNOLOGY
- Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
- (2012) J. Wu et al. SCIENCE
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen
- (2012) Stefano Ugel et al. Cell Reports
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
- (2011) B. C. Burnette et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
- (2011) Kai-ping Han et al. CYTOKINE
- Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes
- (2011) Anne-Hélène Pillet et al. HUMAN IMMUNOLOGY
- Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
- (2011) Cristina Mansilla et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
- (2011) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
- (2011) Marina Caskey et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients
- (2011) C. Alfaro et al. JOURNAL OF IMMUNOLOGY
- Selenite Induces Posttranscriptional Blockade of HLA-E Expression and Sensitizes Tumor Cells to CD94/NKG2A-Positive NK Cells
- (2011) M. Enqvist et al. JOURNAL OF IMMUNOLOGY
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation
- (2011) Carlos Alfaro et al. PLoS One
- B regulatory cells and the tumor-promoting actions of TNF- during squamous carcinogenesis
- (2011) T. Schioppa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The complexity of HDL
- (2010) Gordon A. Francis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
- (2010) Pauline Andreu et al. CANCER CELL
- Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer
- (2010) R. Pio et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells
- (2010) Maria-Elena Márquez et al. CELLULAR IMMUNOLOGY
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
- (2010) M. Gonzalez-Aparicio et al. GUT
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Successful Colon Cancer Eradication after Chemoimmunotherapy Is Associated with Profound Phenotypic Change of Intratumoral Myeloid Cells
- (2010) J. Medina-Echeverz et al. JOURNAL OF IMMUNOLOGY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Pivotal Advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms
- (2010) David J. Kaczorowski et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA
- (2010) Geoffrey W. Stone et al. Journal of Thoracic Oncology
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack
- (2009) Marcin Okroj et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
- (2009) Sarah M. McWhirter et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Promoting Immune Responses by LIGHT in the Face of Abundant Regulatory T Cell Inhibition
- (2009) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The role of the anaphylatoxins in health and disease
- (2009) Andreas Klos et al. MOLECULAR IMMUNOLOGY
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti-neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
- (2008) S. Sharma et al. CANCER RESEARCH
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
- (2008) Michael G. Strainic et al. IMMUNITY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
- Natural killer cell recognition of missing self
- (2008) Klas Kärre NATURE IMMUNOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
- (2007) Marcin Okroj et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now